htrB of Haemophilus influenzae: Determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity

Journal of Endotoxin Research

Volumn 4, Issue 3, 1997, Pages 163-172

  Nichols, W A ^a   Raetz, C R H ^b   Clementz, T ^b   Smith, A L ^c   Hanson, J A ^a   Ketterer, M R ^a   Sunshine, M ^a   Apicella, M A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BRONCHUS MUCOSA; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); BRONCHUS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; LIMULUS; LIMULUS AMOEBOCYTE; MURINAE; NEGIBACTERIA;

EID: 0030786419     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400301     Document Type: Article

References (28)

1. Zwahlen A., Rubin L.G., Moxon E.R. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb Pathogen 1986; 1: 465-473.
2. Kimura A., Hansen E.J. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect Immun 1986; 51: 69-79.
3. Kimura A., Patrick C.C., Miller E.E., Cope L.D., McCracken G.H., Hansen E.J. Haemophilus influenzae type b lipopolysaccharide: stability of expression and association with virulence. Infect Immun 1987; 55: 1979-1986.
4. Gibson B.W., Melaugh W., Phillips N.J., Apicella M.A., Campagnari A.A., Griffiss J.M. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J Bacteriol 1993; 175: 2702-2712.
5. Lee N-G., Sunshine M.G., Apicella M.A. Molecular cloning and characterization of the nontypeable Haemophilus influenzae 2019 rfaE gene required for lipopolysaccharide biosynthesis. Infect Immun 1995; 63: 818-824.
6. Lee N-G., Sunshine M.G., Engstrom J.J., Gibson B.W., Apicella M.A. Mutation of the htrB locus of Haemophilus influenzae nontypeable strain 2019 is associated with modifications of lipid A and phosphorylation of the lipo-oligosaccharide. J Biol Chem 1995; 270: 27151-27159.
7. Clementz T., Bednarski J.J., Raetz C.R.H. Function of the htrB high temperature requirement of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J Biol Chem 1996; 271: 12095-12102.
8. Raetz C.R.H. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol 1993; 175: 5745-5753.
9. Stephens D.S., Farley M.M. Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis 1991; 13: 22-33.
10. Tanamoto K-I. Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity. FEBS Lett 1994; 351: 325-329.
11. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R.H. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.
12. Galanos D., Luderitz O., Rietschel E.T., Westphal O. A new method for the extraction of R lipopolysaccharide. Eur J Biochem 1969; 9: 245-249.
13. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99-105.
14. Smith A.L., Averill D.R., Mariano J., Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun 1973; 8: 278-290.
15. Moxon E.R., Smith A.L., Averill D.R. Jr., Smith D.H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis 1974; 129: 154-162.
16. White K.A., Kaltashov I.A., Cotter R.J., Raetz C.R.H. A monofunctional 3-deoxy-D-manno-octulosonic acid (Kdo) transferase and a Kdo kinase in extracts of Haemophilus influenzae. J Biol Chem 1997; In press.
17. Raetz C.R.H. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles. In: Neidhardt F.C.E.I.C., Curtis R.I., Ingrahm J.L. et al. Eds Escherichia coli and Salmonella: Cellular and Molecular Biology, vol. 1, 2nd edn. Washington DC: ASM Press, 1996; 1035-1063.
18. Raetz C.R.H. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-170.
19. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.
20. Pohlman T.H., Munford R.S., Harlan J.M. Deacylated lipopoly-saccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med 1987; 165: 1393-1402.
21. Loppnow H., Libby P., Freudenberg M., Krauss J.H., Wekesser J., Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.
22. Christ W.H., Asano O., Robidoux A.L. et al. E5531, a pure endotoxin antagonist of extraordinary potency: chemistry and biology. Science 1995; 265: 80-83.
23. Bunnell E., Neumann A., Lynn M. et al. E5531, an endotoxin antagonist, blocks the hyperdynamic and depressant cardiovascular effects of endotoxin in healthy subjects. Crit Care Med Suppl 1995; 23: A151.
24. Kaplan S.L., Hawkins E.P., Inzana T.J., Patrick C.C., Mason E.O.Jr. Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection. Microb Pathogen 1988; 5: 55-62.
25. Somerville Jr J.E., Cassiano L., Bainbridge B., Cunningham M.D., Darveau R.P. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest 1996; 97: 359-365.
26. Clementz T., Zhou Z., Raetz C.R.H. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem 1997; 272: 10353-10360.
27. Anderson P., Johnston R.B., Smith D.H. Human serum activities against Haemophilus influenzae, type b. J Clin Invest 1972; 51: 31-38.
28. Karow M., Fayet O., Cegielska A., Ziegelhoffer T., Georgopoulos C. Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33°C in rich media. J Bacteriol 1991; 173: 741-750.